Related Experiment Videos
Reduction of EGF receptor levels in human tumor cells transfected with an antisense RNA expression vector
Abstract:
An expression vector was constructed from part of pSV2neo with the 3'-ClaI fragment of the epidermal growth factor (EGF) receptor cDNA inserted in an inverted orientation downstream from the human metallothionein (MT) IIa promoter. The human squamous carcinoma cell line NA, which overproduces EGF receptor, was transfected with this vector and selected for resistance to the neomycin derivative G418. One of the stable transfectants had a 90% reduction in cell-surface EGF receptor in response to ZnSO4. The nascent EGF receptor peptide was also decreased with concurrent induction of MT mRNA. These data suggest that the antisense transcript regulated by the MT promoter inhibits the expression of the endogenous EGF receptor genes. Although no transcripts from the antisense gene were detected, the results indicate that transfection with the antisense vector provides a technique by which to modulate the number of EGF receptors on the cell surface of squamous cell carcinomas.
Insights
This study developed an antisense vector to reduce epidermal growth factor (EGF) receptor in squamous cell carcinoma. The vector successfully decreased EGF receptor levels by 90%, offering a potential therapeutic strategy.
Area of Science:
- Molecular Biology
- Oncology
Background:
- Squamous cell carcinomas often overexpress the epidermal growth factor (EGF) receptor.
- Targeting EGF receptor is a key strategy in cancer therapy.
Purpose of the Study:
- To develop and test an antisense vector for downregulating endogenous EGF receptor expression in human squamous carcinoma cells.
- To investigate the potential of metallothionein (MT) promoter-driven antisense transcripts in modulating EGF receptor levels.
Main Methods:
- Construction of an expression vector containing an inverted EGF receptor cDNA fragment under the control of the human MT IIa promoter.
- Transfection of human squamous carcinoma cell line NA with the vector and selection using G418.
- Quantification of cell-surface EGF receptor levels and MT mRNA induction in response to ZnSO4.
Main Results:
- A stable transfectant exhibited a 90% reduction in cell-surface EGF receptor upon ZnSO4 treatment.
- Decreased levels of nascent EGF receptor peptide were observed concurrently with MT mRNA induction.
- The MT promoter-driven antisense transcript is suggested to inhibit endogenous EGF receptor gene expression.
Conclusions:
- Transfection with the designed antisense vector effectively modulates EGF receptor expression in squamous cell carcinoma cells.
- This approach offers a novel technique for reducing EGF receptor levels on cancer cell surfaces.
- The findings support the potential of antisense technology for targeted cancer therapy.